Uzedy Injection, Suspension, Extended Release
Product Images NDC 51759-520

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Uzedy (NDC 51759-520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 1)

An instructional illustration showing a prefilled syringe labeled with parts including cap, white collar, label, plunger stopper, barrel, plunger, and finger flange.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 10)

Illustration showing the correct method for subcutaneous injection of UZEDY (risperidone) extended release suspension. The image shows a syringe with a needle attached to an injection device, with an eye icon and an arrow indicating careful visual attention during use.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 11)

An instructional diagram showing recommended subcutaneous injection sites for UZEDY (risperidone) extended-release suspension. The front view highlights the lower abdomen area, and the back view shows the upper outer arms as injection locations.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 12)

An instructional illustration showing the removal of a protective cap from a prefilled syringe with a needle, depicting hand positioning and directional arrow for correct uncapping procedure.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 13)

An instructional illustration showing a hand pinching skin with two fingers, indicating preparation for a subcutaneous injection. Two red arrows highlight the pinched skin area to guide proper injection technique.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 14)

An instructional diagram showing a hand administering a subcutaneous injection at a 45-degree angle with a syringe. The other hand is holding the skin, demonstrating the proper injection technique likely relevant to UZEDY (risperidone) extended-release suspension injection.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 15)

An instructional illustration showing a hand holding a syringe with a capped needle, positioned above a flat surface. Another hand is shown with an arrow indicating the removal of the cap, demonstrating proper preparation steps for injection administration.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 16)

An instructional diagram showing a hand pressing the plunger of a syringe with the needle inserted into a vial or stopper, demonstrating the technique to withdraw or administer medication for a subcutaneous injection.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 17)

An instructional illustration showing a hand administering a subcutaneous injection using a syringe. A close-up inset highlights the syringe tip being positioned at the injection site on the skin.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 18)

An instructional diagram illustrating a hand holding a syringe with a green needle cap being removed. The illustration shows steps numbered 1, 2, and 3 to guide the removal of the cap before injection.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 19)

An instructional illustration showing a hand holding a syringe and preparing to remove a green cap from a vial or syringe tip. An arrow indicates the direction to pull or twist the cap off, demonstrating a step in medication preparation for subcutaneous injection.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 2)

Illustration of a safety needle showing labeled parts including the needle sheath, needle, safety shield, and hub. The diagram is a simple line drawing intended to identify components of the safety needle.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 20)

An instructional illustration showing a hand holding a syringe with the needle pointing to the left. The index finger is pressing the syringe plunger, indicated by an arrow pointing left, demonstrating how to push or administer the injection suspension subcutaneously.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 21)

Chemical structure diagram of risperidone, the active ingredient in UZEDY injection, suspension, extended release for subcutaneous use.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 22)

A line graph depicting the percentage of patients with impending relapse over time in days from randomization. It compares placebo, UZEDY injection administered once every two months, and UZEDY injection administered once monthly. The y-axis shows percentage of patients with impending relapse, and the x-axis shows time in days. The graph includes a table showing the number of patients at risk at various time points for each group.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 23)

UZEDY 50 mg/0.14 mL injection, suspension, extended release for subcutaneous use. The labeling includes dosing instructions for one month and a single-use indication. The product is packaged by Teva Pharmaceuticals USA, Inc. The carton features a barcode, usage instructions, and storage warnings in a foldable box design.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 24)

Packaging label for UZEDY (risperidone) injection, suspension, extended release, 75 mg/0.21 mL for subcutaneous use. The label highlights a 1 month dosing period, contains important usage instructions, and is manufactured by Teva Pharmaceuticals USA, Inc. The packaging design includes dosing and administration details along with safety warnings.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 25)

UZEDY 100 mg/0.28 mL extended-release injection suspension for subcutaneous use by Teva Pharmaceuticals USA, Inc. The label shows 1 or 2 month dosing instructions, with details on the dosage form and administration route. The packaging includes multiple views with handling and safety information.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 26)

UZEDY 125 mg/0.35 mL extended-release suspension injection for subcutaneous use, packaged by Teva Pharmaceuticals USA, Inc. The label includes instructions to read the full insert before use and details for a 1-month duration dosing. The packaging features dosage strength and volume prominently, barcode, storage information, and Teva branding.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 27)

UZEDY 150 mg/0.42 mL extended-release risperidone injection suspension for subcutaneous use by Teva Pharmaceuticals USA, Inc. The packaging label contains dosing information for 2 months, dosage form, strength, and instructions emphasizing completing dosing before use. It includes manufacturer branding and barcode information on the carton layout.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 28)

UZEDY 200 mg/0.56 mL subcutaneous injection, extended-release suspension for human prescription use. The carton label shows the brand name, strength, volume, dosing duration of 2 months, and is manufactured by Teva Pharmaceuticals USA, Inc. It includes dosing instructions emphasizing use only by healthcare professionals, with additional safety and administration information.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 29)

UZEDY 250 mg/0.7 mL extended-release suspension injection for subcutaneous use, supplied by Teva Pharmaceuticals USA, Inc. The carton features purple and white coloring with dosage strength and route prominently displayed, along with usage instructions and safety warnings on the inner flaps. The package highlights a 2-month dosing interval.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 3)

An instructional illustration indicating a 30-minute duration for a process, labeled with '30 min.' and the phrase 'At room temperature' below, likely related to preparation or administration guidance for the UZEDY injection.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 4)

Instructional illustration showing the UZEDY injection device with a red safety cap and keyhole label, an eye symbol indicating monitoring or visual check, and a view of the injection needle packaging. The diagram visually guides safe use and observation related to the UZEDY subcutaneous extended-release risperidone injection.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 5)

An instructional illustration showing a hand holding a syringe with a focus on the white collar area of the syringe. The inset zoom highlights the correct grip on the syringe near the white collar for administration.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 6)

Illustration showing a three-step process for flicking a syringe downward forcefully using the full arm, with an instruction to repeat the flicking motion three times. The image demonstrates a hand holding a syringe in different downward positions along an arc.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 7)

An illustration showing a UZEDY injection syringe with an expanded view of the syringe's label area, highlighting where to focus or read, indicated by an arrow pointing to an eye observing the label. The image demonstrates proper label viewing on the extended-release risperidone suspension injection.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 8)

An instructional illustration showing hands snapping off the top of a small glass vial or ampule, with the word "SNAP!" indicating the action. The image likely demonstrates the preparation step for the UZEDY (risperidone) injection suspension, extended release, subcutaneous administration.*

FDA Label Image

Image (Uzedy Risperidone Er Inj Susp N213586 9)

An instructional diagram showing a pair of hands demonstrating the removal of a green protective cap by twisting it counterclockwise from the top of a syringe or injection device.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.